Entity Common Stock, Shares Outstanding of IRADIMED CORP from 14 Aug 2014 to 28 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
IRADIMED CORP quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 14 Aug 2014 to 28 Feb 2026.
  • IRADIMED CORP Entity Common Stock, Shares Outstanding for the quarter ending 28 Feb 2026 was 12,782,566, a 0.53% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

IRADIMED CORP Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 12,782,566 +67,457 +0.53% 28 Feb 2026 10-K 06 Mar 2026 2025 FY
Q3 2025 12,715,072 +41,631 +0.33% 31 Aug 2025 10-K/A 03 Sep 2025 2024 FY
Q2 2025 12,720,002 +50,215 +0.4% 30 Jun 2025 10-Q 01 Aug 2025 2025 Q2
Q1 2025 12,715,109 +50,924 +0.4% 30 Apr 2025 10-Q 05 May 2025 2025 Q1
Q3 2024 12,673,441 +67,864 +0.54% 31 Oct 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 12,669,787 +67,114 +0.53% 31 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 12,664,185 +69,388 +0.55% 30 Apr 2024 10-Q 02 May 2024 2024 Q1
Q3 2023 12,605,577 +39,241 +0.31% 31 Oct 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 12,602,673 +37,563 +0.3% 31 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 12,594,797 +34,030 +0.27% 30 Apr 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 12,566,336 +224,586 +1.8% 31 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 12,565,110 +247,083 +2% 31 Jul 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 12,560,767 +248,286 +2% 30 Apr 2022 10-Q 06 May 2022 2022 Q1
Q3 2021 12,341,750 +72,226 +0.59% 01 Nov 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 12,318,027 +75,270 +0.62% 01 Aug 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 12,312,481 +262,503 +2.2% 01 May 2021 10-Q 07 May 2021 2021 Q1
Q3 2020 12,269,524 +784,941 +6.8% 01 Nov 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 12,242,757 +873,250 +7.7% 01 Aug 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 12,049,978 +892,756 +8% 01 May 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 11,484,583 +550,268 +5% 31 Oct 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 11,369,507 +689,375 +6.5% 31 Jul 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 11,157,222 +500,895 +4.7% 30 Apr 2019 10-Q 08 May 2019 2019 Q1
Q3 2018 10,934,315 +379,082 +3.6% 31 Oct 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 10,680,132 +98,089 +0.93% 31 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 10,656,327 -93,568 -0.87% 30 Apr 2018 10-Q 08 May 2018 2018 Q1
Q3 2017 10,555,233 -156,742 -1.5% 31 Oct 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 10,582,043 -90,557 -0.85% 31 Jul 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 10,749,895 -166,716 -1.5% 30 Apr 2017 10-Q 05 May 2017 2017 Q1
Q3 2016 10,711,975 -357,425 -3.2% 31 Oct 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 10,672,600 -346,800 -3.1% 31 Jul 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 10,916,611 -56,852 -0.52% 30 Apr 2016 10-Q 06 May 2016 2016 Q1
Q3 2015 11,069,400 +254,750 +2.4% 31 Oct 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 11,019,400 +301,000 +2.8% 31 Jul 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 10,973,463 30 Apr 2015 10-Q 11 May 2015 2015 Q1
Q3 2014 10,814,650 31 Oct 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 10,718,400 14 Aug 2014 10-Q 14 Aug 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.